logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Drug Safety cover

Drug Safety

IF3.8
Papers3079
Citations6967
Journal Papers 7131
Publication Date
delete
When does Follow-up on Adverse Events Improve the Understanding of Medicine and Vaccine Safety? Insights from Global Expert Perspectives
deleteDrug Safety
IF3.8
delete2026-08-14
delete0
deleteOAAI
deleteVijay Kara; Florence Van Hunsel; Manal Younus; Manfred Hauben; Andrew Bate; Eugène van Puijenbroek
deleteShare
deleteSave
Phloroglucinol Exposure During Early Pregnancy and Risk of Major Congenital Malformations: A Nationwide Cohort Study in France
deleteDrug Safety
IF3.8
delete2026-08-13
delete0
deleteOAAI
deleteAntoine Meyer; Alain Weill; Antoine Rachas; Perrine Capmas; Rosemary Dray-Spira
deleteShare
deleteSave
Optimising Pharmacovigilance Efficiency with MLIT (Machine Learning for Intelligent Triage): A Tool for Statistical Safety Alerts
deleteDrug Safety
IF3.8
delete2026-08-10
delete0
deleteOAAI
deleteLuciano Ciccarelli; Olivia Mahaux; Christie Roshan; Ami Fofana; Anna Kawka; Emilia Occhipinti; Mariapia Possidente; Silvia Cenci; Jeffery L. Painter; Andrew Bate
deleteShare
deleteSave
AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine (Adjuvanted RSVPreF3): Review of the First 2 Years of Post-Marketing Safety Surveillance
deleteDrug Safety
IF3.8
delete2026-08-01
delete0
deleteOAAI
deleteCatherine Tregunno; Quentin Deraedt; Susanna Cuadripani; Céline Verheust; Philip Bryan
deleteShare
deleteSave
Incident Neutropenia in New Users of Different Non-opioid Analgesics: An Observational Propensity Score-Controlled Cohort Study
deleteDrug Safety
IF3.8
delete2026-07-31
delete0
deleteOAAI
deleteStephan Gut; Marlene Rauch; Jan Gaertner; Susan S. Jick; Christoph R. Meier; Julia Spoendlin
deleteShare
deleteSave
Implementation Science for Effective Risk Management of Medicines: A Call for Global Action
deleteDrug Safety
IF3.8
delete2026-07-30
delete0
deleteOAAI
deleteMeredith Y. Smith; Priya Bahri; Delese Mimi Darko; Alex N. O. Dodoo; Adrien Inoubli; Elaine H. Morrato; Christine Perera; Shanti Pal
deleteShare
deleteSave
Correction: The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis
deleteDrug Safety
IF3.8
delete2026-07-27
delete0
PREAI
deleteManfred Hauben; Rave Harpaz
deleteShare
deleteSave
Transient Oral Corticosteroid Use and Acute Upper Gastrointestinal Bleeding in Mild-to-Moderate Asthma: A Case-Crossover Study
deleteDrug Safety
IF3.8
delete2026-07-23
delete0
PREAI
deleteJiaying Li; Pierre Ernst; Samy Suissa
deleteShare
deleteSave
Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase
deleteDrug Safety
IF3.8
delete2026-07-22
delete0
deleteOAAI
deleteNicoletta Luxi; Chiara Bellitto; Francesco Ciccimarra; Fabio Scapini; Elena Arzenton; Francesco Maccarrone; Ugo Moretti; Emanuel Raschi; Elisabetta Poluzzi; Daniele Focosi; Jacopo Angelini; Pasquale De Nardo; Alessia Savoldi; Evelina Tacconelli; Gianluca Trifirò; Marco Tuccori
deleteShare
deleteSave
Presence of Benzodiazepines in Aquatic Environments: A Systematic Review of the Literature
deleteDrug Safety
IF3.8
delete2026-07-21
delete0
deleteOAAI
deleteJacopo Grisotto; Irene Cristini; Salvatore Crisafulli; Francesco Ciccimarra; Francesca Patuzzi; Federica Soardo; Elisabetta Mariavittoria Giunco; Giovanna Paolone; Gianluca Trifirò
deleteShare
deleteSave
Ponatinib Safety Profile: An Analysis of 10 Years of Real-World Experience
deleteDrug Safety
IF3.8
delete2026-07-18
delete0
deleteOAAI
deleteElias Jabbour; Fausto Castagnetti; Mouna Bardey-Kanaan; Romuald Soichez; Nhan Thanh Nguyen; Deborah Kelly; Federica Rizzo; Petros Patos; Valentín García-Gutiérrez
deleteShare
deleteSave
Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia
deleteDrug Safety
IF3.8
delete2026-07-15
delete0
PREAI
deleteSikander Ailawadhi; Elcin Omercikoglu; Aneel Paulus; Ricardo D. Parrondo; Asher A. Chanan-Khan
deleteShare
deleteSave
Augmenting Medical Judgment in Signal Confirmation: Design Considerations for an AI-Enabled Causality Assessment Framework
deleteDrug Safety
IF3.8
delete2026-07-15
delete0
deleteOAAI
deleteTarek A. Hammad; Justine Rochon; Salman Afsar; Sue H. Lee; Dona M. Ely; Neda Hassanpour; Andrew Bate
deleteShare
deleteSave
Enhancing Disease Surveillance and Pharmacovigilance Practices for RTS,S/AS01E Malaria Vaccine Rollout in Ghana, Kenya, and Malawi: Strategies, Impact, Challenges, and Lessons Learned
deleteDrug Safety
IF3.8
delete2026-07-14
delete0
deleteOAAI
deleteValérie Haine; Tene-Alima Essoh; Caroline Perrin Franck; Miloje Savic
deleteShare
deleteSave
Sexual Dysfunction Among Males Living with HIV Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A Cross-sectional Study
deleteDrug Safety
IF3.8
delete2026-07-13
delete0
deleteOAAI
deleteRonald Kiguba; Mishael Ssesanga; Eva Agnes Laker Odongpiny; Munir Pirmohamed
deleteShare
deleteSave
Retraction Note: Hydroxyethylstarch as a Risk Factor for Acute Renal Failure
deleteDrug Safety
IF3.8
delete2026-07-09
delete0
PREAI
deleteJoachim Boldt
deleteShare
deleteSave
Implementation Aspects of a Medicines Shortage Policy Tool: Evidence from Australia's Serious Scarcity Substitution Instruments
deleteDrug Safety
IF3.8
delete2026-07-02
delete0
deleteOAAI
deleteJack Janetzki; Lisa Kalisch-Ellett; Nicole Pratt; Anna Kemp-Casey
deleteShare
deleteSave
Availability and Communication of Risk Management Strategies for Pregnancy Category X Medicines across Australian Medicine Information Sources
deleteDrug Safety
IF3.8
delete2026-07-01
delete0
deleteOAAI
deleteHelen Mayer; Jacquelina Stasinopoulos; Bronni Simpson; Jessica Gehlert; Luke E. Grzeskowiak
deleteShare
deleteSave
The Bidirectionality of Lawyer Reporting Bias in Disproportionality Analysis
deleteDrug Safety
IF3.8
delete2026-07-01
delete0
PREAI
deleteManfred Hauben; Rave Harpaz
deleteShare
deleteSave
Safety of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: A Longitudinal Analysis
deleteDrug Safety
IF3.8
delete2026-06-26
delete0
deleteOAAI
deleteKuan Peng; Vincent K. C. Yan; Shirley C. W. Chan; Ju-Young Shin; Edward Chia‑Cheng Lai; Nicole L. Pratt; Esther W. Y. Chan; Chak-sing Lau; Xue Li
deleteShare
deleteSave